Related Experiment Video
Updated: Aug 15, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Her choice: dealing with lactobacilli, vaginitis, and antibiotics
Marie V Pirotta1, Suzanne M Garland
1Department of General Practice, University of Melbourne, 200 Berkeley Street, Carlton, 3053, Victoria, Australia. m.pirotta@unimelb.edu.au
Vulvovaginal candidiasis (VVC) is common, but knowledge gaps persist regarding its causes and antibiotic links. Evidence supporting Lactobacillus probiotics for VVC is lacking, warranting further research.
Area of Science:
- Mycology
- Immunology
- Microbiology
Background:
- Vulvovaginal candidiasis (VVC) is a prevalent condition affecting women.
- Significant knowledge gaps exist regarding Candida pathogenesis, host immunity, and the association with antibiotic use.
- Self-diagnosis and self-management are common, including the use of probiotics like Lactobacillus.
Purpose of the Study:
- To explore the current understanding of VVC.
- To address the lack of evidence for Lactobacillus's efficacy in managing VVC.
- To identify areas for future research in VVC pathogenesis and treatment.
Main Methods:
- Literature review and synthesis of existing research on VVC.
- Analysis of the biological plausibility and evidence for Lactobacillus interventions.
- Identification of research gaps and future directions.
Main Results:
- The pathogenesis and immune responses in VVC are not fully understood.
- The purported benefits of Lactobacillus probiotics for VVC lack a clear biological mechanism and rigorous supporting evidence.
- Current management often relies on self-treatment with limited scientific validation.
Conclusions:
- Further research is crucial to elucidate VVC pathogenesis and host immunity.
- The effectiveness of Lactobacillus for VVC requires robust scientific investigation.
- Addressing knowledge gaps is essential for improving VVC management strategies.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Antibiotic Selection
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Microbiota Modulation by Antibiotics
Clinical Significance of Antibiotic Resistance
Microbiota of the Urogenital Tract
